Dwight H Egan Co Diagnostics, Inc. (CODX) insider trading activity

Dwight H Egan is Chief Executive Officer of Co-Diagnostics, Inc.. Currently has a direct ownership of 522,858 shares of CODX, which is worth approximately $465,343. The most recent transaction as insider was on Nov 23, 2024, when has been sold 49,689 shares (Common Stock) at a price of $1.01 per share, resulting in proceeds of $50,185. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 523K

42.39% 3M change

93.02% 12M change

Total Value Held $465,343

Dwight H Egan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 23 2024	SELL Sale (or disposition) back to the issuer	$50,185 $1.01 p/Share	49,689 Reduced 8.68%	522,858 Common Stock
Nov 23 2024	BUY Grant, award, or other acquisition	-	163,333 Added 22.2%	572,547 Common Stock
May 23 2024	SELL Sale (or disposition) back to the issuer	$45,788 $1.09 p/Share	42,008 Reduced 10.27%	367,206 Common Stock
May 23 2024	BUY Grant, award, or other acquisition	-	138,333 Added 25.26%	409,214 Common Stock
Nov 23 2023	SELL Sale (or disposition) back to the issuer	$58,019 $1.26 p/Share	46,047 Reduced 14.53%	270,881 Common Stock
Nov 23 2023	BUY Grant, award, or other acquisition	-	150,834 Added 32.25%	316,928 Common Stock
May 23 2023	SELL Sale (or disposition) back to the issuer	$42,375 $1.32 p/Share	32,103 Reduced 16.2%	166,094 Common Stock
May 23 2023	BUY Grant, award, or other acquisition	-	105,000 Added 34.63%	198,197 Common Stock
Nov 23 2022	SELL Sale (or disposition) back to the issuer	$111,421 $3.47 p/Share	32,110 Reduced 25.63%	93,197 Common Stock
Nov 23 2022	BUY Grant, award, or other acquisition	-	79,166 Added 38.72%	125,307 Common Stock
May 23 2022	SELL Sale (or disposition) back to the issuer	$59,151 $4.99 p/Share	11,854 Reduced 20.44%	46,141 Common Stock
May 23 2022	BUY Grant, award, or other acquisition	-	33,334 Added 36.5%	57,995 Common Stock
Nov 23 2021	SELL Payment of exercise price or tax liability	$131,191 $8.44 p/Share	15,544 Reduced 38.66%	24,661 Common Stock
Nov 23 2021	BUY Grant, award, or other acquisition	-	33,333 Added 45.33%	40,205 Common Stock
May 24 2021	SELL Payment of exercise price or tax liability	$44,461 $7.9 p/Share	5,628 Reduced 45.02%	6,872 Common Stock
May 24 2021	BUY Grant, award, or other acquisition	-	12,500 Added 50.0%	12,500 Common Stock
Jan 15 2021	SELL Payment of exercise price or tax liability	$31,439 $2.63 p/Share	11,954 Reduced 23.91%	38,046 Common Stock
Jan 15 2021	SELL Open market or private sale	$418,506 $11.0 p/Share	38,046 Reduced 100.0%	0 Common Stock
Jan 15 2021	BUY Exercise of conversion of derivative security	$131,500 $2.63 p/Share	50,000 Added 50.0%	50,000 Common Stock
Nov 24 2020	SELL Open market or private sale	$470,470 $10.51 p/Share	44,764 Reduced 100.0%	0 Common Stock
Nov 24 2020	SELL Payment of exercise price or tax liability	$5,760 $1.1 p/Share	5,236 Reduced 10.47%	44,764 Common Stock
Nov 24 2020	BUY Exercise of conversion of derivative security	$55,000 $1.1 p/Share	50,000 Added 50.0%	50,000 Common Stock
Nov 23 2020	SELL Open market or private sale	$747,180 $10.44 p/Share	71,569 Reduced 100.0%	0 Common Stock
Nov 23 2020	SELL Payment of exercise price or tax liability	$9,274 $1.1 p/Share	8,431 Reduced 10.54%	71,569 Common Stock
Nov 23 2020	BUY Exercise of conversion of derivative security	$88,000 $1.1 p/Share	80,000 Added 50.0%	80,000 Common Stock

DHE

Dwight H Egan

Chief Executive Officer

Salt Lake City, UT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CODX shares.

Notify only if

Value

Insider Trading

Get notified when an Co Diagnostics, Inc. insider buys or sells CODX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Co-Diagnostics, Inc.

Track Activities on CODX

Account